SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
批准号:
3916617
负责人:
E SAUSVILLE
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
antibody specificity bombesin cell cell interaction cell growth regulation cell membrane cellular oncology cholera toxin crosslink drug design /synthesis /production gastrins guanosine diphosphate hormone binding protein hormone receptor human tissue laboratory rat molecular oncology neoplasm /cancer therapy neoplastic cell oncoproteins peptide hormone pertussis toxin pituitary gland second messengers small cell lung cancer
中文摘要
以前对小细胞肺癌(SCLC)细胞系的研究表明,
证明了胃泌素释放肽(GRP),哺乳动物
蛙皮素的对应物,在
SCLC线路。 为了评估其在引起自分泌刺激中的作用,
最初的实验试图证明特异性结合
SCLC膜组分,但收效甚微。 因此,努力
以确定对GRP的快速生理反应。
这些研究清楚地表明,在5/11的SCLC细胞系中,
测试有证据表明,钙动员后,GRP或
蛙皮素刺激 这种结构与活性的关系
作用与对肠道中GRP受体预期的雅阁,
脑和垂体前叶细胞。 进一步的研究集中在
这种反应与磷酸肌醇代谢的关系。
在SCLC细胞系中,对GRP的反应活跃,
细胞内钙,有证据表明增加肌醇
在添加蛙皮素的几秒钟内1,4,5三磷酸盐
同类物。 钙和磷酸肌醇的动员
霍乱毒素和活性佛波醇酯抑制周转。
在百日咳毒素的存在下,
刺激磷酸肌醇周转。 在推论研究中,
结果表明,对以下物质具有最佳应答的细胞系
蛙皮素呈组成型表达,L-myc和prepro GRP
而不表达c-或N-myc。 相反,没有
对蛙皮素反应的证据具有组成性N-或c-myc
表情
这些研究表明,进行性恶性和
可以在SCLC细胞系中定义不同的表型。 一个最
“分化的”细胞系将是那些产生和响应
转化成GRP,并产生L-myc。 分化程度较低的细胞系
不会产生GRP,也不会对GRP产生反应,并表达丰富的c-
或N-myc。 GRP(+)、L-myc(+)、c-myc(-)和N-myc(-)细胞系
将代表那些试图阻止潜在的
涉及GRP的自分泌环可能是最成功的。
英文摘要
Previous studies with small cell lung cancer (SCLC) cell lines have
demonstrated that gastrin-releasing peptide (GRP), the mammalian
counterpart to bombesin, is expressed in a significant fraction of
SCLC lines. To assess its role in causing autocrine stimulation,
initial experiments attempted to demonstrate specific binding to
SCLC membrane fractions, with little success. Accordingly, efforts
to define rapid physiologic responses to GRP were undertaken.
These studies demonstrated clearly that in 5/11 SCLC cell lines
tested there was evidence of calcium mobilization following GRP or
bombesin stimulation. The structure-activity relationship of this
effect was in accord with that expected for GRP receptors in gut,
brain and anterior pituitary cells. Further studies focused on the
relationship of this response to inositol phosphate metabolism.
In a SCLC cell line with a brisk response to GRP with increased
intracellular calcium, there was evidence of increased inositol
1,4,5 trisphosphate within seconds of addition of bombesin
congeners. Both the mobilization of calcium and inositol phosphate
turnover were inhibited by cholera toxin and active phorbol esters.
In the presence of pertussis toxin there was also a less complete
stimulation of inositol phosphate turnover. In corollary studies
it was demonstrated that the cell lines with the best response to
bombesin showed constitutive expression of L-myc and prepro GRP
without expression of c- or N-myc. In contrast, cell lines without
evidence of response to bombesin had constitutive N- or c-myc
expression.
These studies suggest that an order of progressively malignant and
distinct phenotypes can be defined in SCLC cell lines. A most
"differentiated" cell line would be those which produce and respond
to GRP, and also produce L-myc. A less differentiated cell line
would neither produce nor respond to GRP and express abundant c-
or N-myc. GRP (+), L-myc (+), c-myc (-), and N-myc (-) cell lines
would represent those in which an effort to block a potential
autocrine loop involving GRP might be most successful.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMMUNOTOXIN PROTOCOLS
-
批准号:5201307
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
-
批准号:3939550
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
ENDOTHELIAL CELL TARGETED CANCER TREATMENT
-
批准号:3838151
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
TOXINS TARGETED TO THE CELL MEMBRANE--DISRUPTION OF SIGNAL TRANSDUCTION
-
批准号:3752418
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
PRECLINICAL AND CLINICAL PHARMACOLOGY OF PROTEIN KINASE ANTAGONISTS
-
批准号:3752419
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
G-PROTEIN EFFECTORS AS TARGETS FOR ANTINEOPLASTIC THERAPIES
-
批准号:3774670
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
PROTEIN KINASE ANTAGONISTS--PRECLINICAL AND CLINICAL STUDIES
-
批准号:2464490
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
ENDOTHELIAL CELL TARGETED CANCER TREATMENT
-
批准号:3752421
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
ENDOTHELIAL CELL TARGETED CANCER TREATMENT
-
批准号:3774671
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
PRECLINICAL PHARMACOLOGY OF PROTEIN KINASE ANTAGONISTS
-
批准号:3853203
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
TOXINS TARGETED TO THE CELL MEMBRANE--DISRUPTION OF SIGNAL TRANSDUCTION
-
批准号:5201344
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
PRECLINICAL AND CLINICAL PHARMACOLOGY OF PROTEIN KINASE ANTAGONISTS
-
批准号:5201345
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
G-PROTEIN EFFECTORS AS TARGETS FOR ANTINEOPLASTIC THERAPIES
-
批准号:3838150
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
G-PROTEIN EFFECTORS AS TARGETS FOR ANTINEOPLASTIC THERAPIES
-
批准号:3752420
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
TOXINS TARGETED TO THE CELL MEMBRANE--DISRUPTION IN SIGNAL TRANSDUCTION
-
批准号:3774668
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
TOXINS TARGETED TO THE CELL MEMBRANE--DISRUPTION IN SIGNAL TRANSDUCTION
-
批准号:3838148
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
IMMUNOTOXIN PROTOCOLS--TARGETED THERAPY OF LYMPHOID NEOPLASMS
-
批准号:6123682
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
LINEAGE-SPECIFIC MARKER AND PROTO-ONCOGENE EXPRESSION IN HUMAN LUNG CANCER
-
批准号:3939551
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
PRECLINICAL AND CLINICAL PHARMACOLOGY OF PROTEIN KINASE ANTAGONISTS
-
批准号:3774669
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
-
批准号:3963280
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:E SAUSVILLE
-
依托单位:
国内基金
海外基金
Bombesin修饰的纳米粒肿瘤靶向性及靶向递药效果研究
-
批准号:81603018
-
项目类别:青年科学基金项目
-
资助金额:17.3万元
-
批准年份:2016
-
负责人:刘珊
-
依托单位:
Bombesin导向的肿瘤细胞选择性促凋亡分子优化设计及PEG定点修饰
-
批准号:81072566
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2010
-
负责人:卢晓风
-
依托单位: